Form 8-K - Current report:
SEC Accession No. 0001104659-11-064619
Filing Date
2011-11-16
Accepted
2011-11-16 16:17:55
Documents
1
Period of Report
2011-11-16
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K a11-30055_18k.htm 8-K 24266
  Complete submission text file 0001104659-11-064619.txt   25148
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 111210237
SIC: 2834 Pharmaceutical Preparations